Канал: Neuroblastoma Parent Global Symposium

Wrap-Up and Video Tribute, featuring children from around the globe.

Wrap-Up and Video Tribute, featuring children from around the globe.

Welcome and Opening Session

Welcome and Opening Session

CAR T Cells in the Clinic

CAR T Cells in the Clinic

Advocacy in Research

Advocacy in Research

Landscape Overview

Landscape Overview

Neuroblastoma has shaped but not defined me

Neuroblastoma has shaped but not defined me

The Impact of Chemotherapy on Hearing

The Impact of Chemotherapy on Hearing

Psycho-Social Cancer Toolbox

Psycho-Social Cancer Toolbox

Induction Protocol Update from Memorial Sloan Kettering

Induction Protocol Update from Memorial Sloan Kettering

CAR-T Cell Therapies - Where are we now (edited for unpublished data)

CAR-T Cell Therapies - Where are we now (edited for unpublished data)

Anti GD2 Antibody Therapy - an important approach in the treatment of neuroblastoma

Anti GD2 Antibody Therapy - an important approach in the treatment of neuroblastoma

2022 Closing and Video Tribute

2022 Closing and Video Tribute

The Challenge of Curing High-risk Neuroblastoma

The Challenge of Curing High-risk Neuroblastoma

Treating High-risk Neuroblastoma - Where are we now?

Treating High-risk Neuroblastoma - Where are we now?

Post Treatment: A Parent's Perspective

Post Treatment: A Parent's Perspective

NPGS 2021 Closing Remarks with Montage

NPGS 2021 Closing Remarks with Montage

Challenges After Treatment with adult survivor stories

Challenges After Treatment with adult survivor stories

Advances in Immunotherapy

Advances in Immunotherapy

The Role of High Dose Chemotherapy in Neuroblastoma

The Role of High Dose Chemotherapy in Neuroblastoma

Maintenance Therapies

Maintenance Therapies

Progress in Neuroblastoma Clinical Trials: where we’ve come from & where we’re going

Progress in Neuroblastoma Clinical Trials: where we’ve come from & where we’re going

If Treatment Doesn't Go to Plan

If Treatment Doesn't Go to Plan

2021 Opening remarks with Dr. Daniel Morgenstern

2021 Opening remarks with Dr. Daniel Morgenstern

Coping with Diagnosis

Coping with Diagnosis

Current Research Directions Polyamine Inhibition Projects, CBL0137, BCT 100 and New Discoveries

Current Research Directions Polyamine Inhibition Projects, CBL0137, BCT 100 and New Discoveries

Current Research Personalised Medicine and Zero Childhood Cancer Project including PRISM

Current Research Personalised Medicine and Zero Childhood Cancer Project including PRISM

Cell Therapies in Neuroblastoma: Panel Session

Cell Therapies in Neuroblastoma: Panel Session

2020 Closing Ceremony with Survivor Stories

2020 Closing Ceremony with Survivor Stories

SIOPEN/ITCC Relapse Strategy & Trials

SIOPEN/ITCC Relapse Strategy & Trials

Seeking a Second Opinion & REDMAPP Study

Seeking a Second Opinion & REDMAPP Study

Molecular Radiotherapy for Neuroblastoma

Molecular Radiotherapy for Neuroblastoma

Being a Teenager/Young Adult on Treatment

Being a Teenager/Young Adult on Treatment

Transitioning to Adulthood

Transitioning to Adulthood

MiNivAn: MIBG and antibody combination therapy

MiNivAn: MIBG and antibody combination therapy

COG/SIOPEN Frontline Studies

COG/SIOPEN Frontline Studies

COG/NANT Relapse Strategy and Trials

COG/NANT Relapse Strategy and Trials

Low & Intermediate Risk Neuroblastoma

Low & Intermediate Risk Neuroblastoma

Neuroblastoma Drug Development Strategy (NDDS): New Therapeutic Targets & Strategies

Neuroblastoma Drug Development Strategy (NDDS): New Therapeutic Targets & Strategies

Pain and Pain Management

Pain and Pain Management

DFMO Studies at the Beat Childhood Cancer Consortium

DFMO Studies at the Beat Childhood Cancer Consortium

Bivalent Vaccine Studies

Bivalent Vaccine Studies

Ask the Experts Q&A Panel Session

Ask the Experts Q&A Panel Session

Neuroblastoma Research: A Global Perspective

Neuroblastoma Research: A Global Perspective

Developing New Treatment Approaches to HR Neuroblastoma

Developing New Treatment Approaches to HR Neuroblastoma

ANZCHOG Treatment and Trials Update

ANZCHOG Treatment and Trials Update

Coping as a Family and Accessing Support Services

Coping as a Family and Accessing Support Services

Neuroblastoma Basics: Introduction to Neuroblastoma

Neuroblastoma Basics: Introduction to Neuroblastoma

Neuroblastoma Basics: Ask the Experts

Neuroblastoma Basics: Ask the Experts

Targeting ALK - From Discovery to Frontline Treatment

Targeting ALK - From Discovery to Frontline Treatment

Dealing with a Childhood Cancer Diagnosis

Dealing with a Childhood Cancer Diagnosis

Omburtamab (8H9) for CNS Relapse

Omburtamab (8H9) for CNS Relapse

Post-traumatic Stress and PTSD in Pediatric Cancer Survivors and Parents

Post-traumatic Stress and PTSD in Pediatric Cancer Survivors and Parents

Naxitamab (hu3F8) Studies

Naxitamab (hu3F8) Studies

The Importance of Aftercare / Long Term Follow Up

The Importance of Aftercare / Long Term Follow Up

2020 Opening Ceremony

2020 Opening Ceremony